M&A Corner
Kinnate Biopharma Inc. Announces Acquisition of Ownership Stake from Series a Investors of the China Joint Venture, Kinnjiu Biopharma Inc., and Initiation of Phase 1 Clinical Trial for Exarafenib (KIN-2787) in People’s Republic of China27 Feb 2023
Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced that it has acquired ownership stake of... Continue Reading
|
Donaldson Acquires Isolere Bio, Continuing to Build Life Sciences Business27 Feb 2023
Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced the acquisition of... Continue Reading
|
Lunit Opens European Unit to Hasten Expansion27 Feb 2023
South Korean medical AI company Lunit has announced its decision to establish a wholly-owned subsidiary in Europe. According to a... Continue Reading
|
Molbio Diagnostics Acquires Majority Stake in Prognosys Medical Systems27 Feb 2023
Molbio Diagnostics has announced that it has acquired a 70 per cent stake in Bengaluru-based Prognosys Medical Systems, a manufacturer... Continue Reading
|
Elevance Health Acquires Specialty Pharmacy Company BioPlus27 Feb 2023
Elevance Health has finalized its acquisition of BioPlus, a specialty pharmacy subsidiary of CarepathRx and a portfolio company of Nautic... Continue Reading
|
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss Pending Merger21 Feb 2023
Sesen Bio, Inc. (Nasdaq: SESN) today announced that members of its management team will host a fireside chat with members... Continue Reading
|
Elation Health Acquires Lightning MD to Build Primary Care All-in-one Solution21 Feb 2023
What You Should Know: – Primary care EHR Elation Health acquires cloud-based medical billing and payer connectivity provider Lightning MD,... Continue Reading
|
BML, One of Sesen Bio’s Top Stockholders, Announces Support for Pending Merger with Carisma Therapeutics21 Feb 2023
Sesen Bio, Inc. (Nasdaq: SESN) (“Sesen Bio” or the “Company”), today announced that BML Investment Partners, L.P. (“BML”), one of... Continue Reading
|
Centura Health Acquires Utah Care Sites from Steward Health Care21 Feb 2023
What You Should Know: Centura Health, one of its two joint operating sponsors, CommonSpirit Health, and Steward Health Care today... Continue Reading
|
RadioMedix Inc. Announces the Acquisition of Its 225Ac-PSMA I&T Program, a Targeted Alpha Therapy (TAT) for Metastatic Castration-resistant Prostate Cancer, By Fusion Pharmaceuticals Inc.21 Feb 2023
RadioMedix Inc. (“RadioMedix” or “Company”), a clinical-stage radiopharmaceutical company announced the acquisition of it’s 225Ac-PSMA-I&T asset by Fusion Pharmaceuticals. Fusion... Continue Reading
|